Skip to main content
SpringerLink
Log in
Book cover

Urologic Oncology

  • Book
  • © 1984

Overview

Editors:
  1. Timothy L. Ratliff

    1. Division of Urology, Washington University School of Medicine, St. Louis, USA
      The Jewish Hospital of St. Louis, St. Louis, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. William J. Catalona

    1. Division of Urology, Washington University School of Medicine, St. Louis, USA
      The Jewish Hospital of St. Louis, St. Louis, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Cancer Treatment and Research (CTAR, volume 19)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (13 chapters)

  1. Front Matter

    Pages i-xiii
    Download chapter PDF

  2. Tumor Angiogenesis: Importance in Tumor Detection and Growth

    • Gerald W. Chodak, Judah Folkman
    Pages 1-16

  3. Role of Androgen Receptors in Stromal-Epithelial Interactions in Prostatic Cancer

    • Leland W. K. Chung, Timothy C. Thompson, Audrey K. Rocco, Abdulmaged M. Traish, Herbert H. Wotiz
    Pages 17-49

  4. Chemotherapy in Prostatic Cancer

    • Joseph R. Drago, Jack S. Elder
    Pages 51-87

  5. In Vitro Assays for Directing Therapy of Genitourinary Cancers

    • Jonathan Fleischmann, Warren D. W. Heston, William R. Fair, Michael M. Lieber
    Pages 89-109

  6. Tumor Markers in Genitourinary Cancer

    • H. Barton Grossman, T. Ming Chu
    Pages 111-137

  7. Role of Conservative Surgery for Patients with Bilateral Kidney Tumors

    • Stephen C. Jacobs, Andrew C. Novick
    Pages 139-168

  8. BCG Therapy for Superficial Bladder Cancer

    • David R. Kelley, William J. Catalona, Donald L. Lamm
    Pages 169-187

  9. Differentiation in Teratocarcinoma: Its Implications in Therapy

    • Perinchery Narayan, William C. Dewolf, Wendell C. Speers
    Pages 189-209

  10. Interferon as an Antitumor Agent for Urologic Tumors

    • Timothy L. Ratliff, Amos Shapiro, William J. Catalona, Mathilde Krim
    Pages 211-253

  11. Surgical Management of Post-Chemotherapy Residual Testis Tumor

    • Randall G. Rowland, Michael A. S. Jewett
    Pages 255-277

  12. Prognostic Value of HLA in Genitourinary Tumors

    • Arthur I. Sagalowsky, Marilyn S. Pollack
    Pages 279-305

  13. Luteinizing Hormone Releasing Hormone Analog Agonists in the Treatment of Advanced Prostatic Cancer

    • John Trachtenberg, Joseph A. Smith Jr.
    Pages 307-315

  14. Nuclear Magnetic Resonance (NMR) Imaging in Urologic Oncology

    • Richard D. Williams, Hedvig Hricak, Jeffrey H. Newhouse
    Pages 317-360

  15. Back Matter

    Pages 361-367
    Download chapter PDF
Back to top

Keywords

About this book

The study of genitourinary tumors is an area of recent rapid growth both in the understanding of disease processes and in the development of new diagnostic and therapeutic modalities. During rapid growth phases within any field, it is desirable to reflect on the current 'state of the art'. It is difficult even for experts in reputed areas of advancement to distinguish true advances from false leads, but it is far more difficult yet for those whose expertise lies in other areas to evaluate important advances. Thus, an objective assessment of evolving areas of investigation in the form of a comprehensive review is of considerable value. we have attempted to provide the reader with an over­ In this volume, view of some of the current areas of investigation in urologic oncology by experts in each area. There often is a tendency for invited papers in books of this nature to lack important critical peer review and therefore, suffer from a lack of objectivity. We have attempted to diminish this problem by the selection of two experts to discuss each subject. We believe that this format has improved the overall quality of the book for two reasons: 1) the know­ ledge of each contributor that his or her work would be reviewed by a peer 2) the fact that contributions by encourages more rigorous scholarship, and two experts, including the individual insights of each, provides a better per­ spective for the reader.

Editors and Affiliations

  • Division of Urology, Washington University School of Medicine, St. Louis, USA

    Timothy L. Ratliff, William J. Catalona

  • The Jewish Hospital of St. Louis, St. Louis, USA

    Timothy L. Ratliff, William J. Catalona

Bibliographic Information

  • Book Title: Urologic Oncology

  • Editors: Timothy L. Ratliff, William J. Catalona

  • Series Title: Cancer Treatment and Research

  • DOI: https://doi.org/10.1007/978-1-4613-2843-8

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Martinus Nijhoff Publishers, Boston 1984

  • Hardcover ISBN: 978-0-89838-628-8Published: 30 June 1984

  • Softcover ISBN: 978-1-4612-9795-6Published: 17 September 2011

  • eBook ISBN: 978-1-4613-2843-8Published: 06 December 2012

  • Series ISSN: 0927-3042

  • Series E-ISSN: 2509-8497

  • Edition Number: 1

  • Number of Pages: XIV, 368

  • Topics: Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation